Quince Therapeutics (QNCX) Tax Rate (2022 - 2026)
Quince Therapeutics (QNCX) posted Tax Rate of 0.13% for Q2 2026, up 99.24% on a QoQ basis from 17.46% in Q1 2026, and up 29.0% year-over-year from 0.1% in Q2 2025.
Analysis
Quince Therapeutics (QNCX) Tax Rate (2022 - 2026) Analysis & Trends
Quince Therapeutics has reported Tax Rate for 5 years, with the latest figure at 0.13% in Q2 2026.
- On a quarterly basis, Tax Rate rose 29.0% year-over-year to 0.13% in Q2 2026; TTM through Jun 2026 was 23.58%, a 2394.0% increase from a year earlier, with the FY2025 full-year figure at 21.0%, up 2123.0% from the prior year.
- Tax Rate was 0.13% for Q2 2026 at Quince Therapeutics, up from 17.46% in the prior quarter.
- The five-year high for Tax Rate was 46.9% in Q4 2025, with the low at 17.46% in Q1 2026.
- Average Tax Rate over 5 years is 2.38%, with a median of 0.24% recorded in 2024.
- The sharpest annual moves came in 2025 and 2026: Tax Rate soared 4731 bps in 2025, then tumbled 1715 bps in 2026.
- Over 5 years, Tax Rate stood at 1.69% in 2022, then tumbled by 134 bps to 0.58% in 2023, then grew by 28 bps to 0.42% in 2024, then jumped by 11329 bps to 46.9% in 2025, then tumbled by 100 bps to 0.13% in 2026.
- The last three Tax Rate figures came in at 0.13% (Q2 2026), 17.46% (Q1 2026), and 46.9% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.34% |
| 10 | Quince Therapeutics | 175.52 Mn | 175.52 Mn | - | -0.13% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.13% |
| Mar 31, 2026 | -17.46% |
| Dec 31, 2025 | 46.90% |
| Sep 30, 2025 | 0.34% |
| Jun 30, 2025 | -0.42% |
| Mar 31, 2025 | -0.31% |
| Dec 31, 2024 | -0.42% |
| Sep 30, 2024 | -0.24% |
| Jun 30, 2024 | -0.13% |
| Mar 31, 2024 | -0.28% |
| Dec 31, 2023 | -0.58% |
| Mar 31, 2023 | 1.98% |
| Jun 30, 2022 | 1.69% |